Answers are grounded in this paper and cite their sources.
Approximately 10% to 15% of ischemic strokes are associated with cancer; cancer-associated stroke, particularly when cryptogenic, is associated with high rates of recurrent stroke and major bleeding. Limited data exist on the safety and efficacy of different antithrombotic strategies in patients with cancer and cryptogenic stroke.
No takes yet. Share an insight, caveat, or question.
Navi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: